Supply Chain Management
Supply Chain Management
Supply Chain Management
GlaxoSmithKline Profile
GlaxoSmithKline (GSK) is one of the worlds largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000
BRIEF HISTORY
Year Merger/Acquisition New Company Name
1989
Beecham merged with SmithKline Beckman Glaxo acquires Burroughs Wellcome & Co. Glaxo Wellcome merged with SmithKline Beecham GlaxoSmithKline acquires consumer health care company Block Drug Co.
SmithKline Beecham
1995
Glaxo Wellcome
2000
GlaxoSmithKline
2001
GlaxoSmithKline
GSK Products
GSK produce medicines for major diseases such as asthma, anti-virals, infections, mental health, diabetes, cardiovascular and digestive conditions. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer.
Other Products
Over the counter(OTC)medicines: Gaviscon and Panadol dental products such as Aquafresh and Sensodyne smoking control products Nicorette/Niquitin nutritional healthcare drinks such as Lucozade, Ribena and Horlicks skincare products marketed by Stiefel Laboratories
Operational Characteristics
Glaxo has been profiled in some areas; i. Quality Functions. ii. Supply Base management. iii. Manufacturing Process Ownership. iv. Quality in R&D. v. Best Purchase- Supplier Collaboration.
VMI IN GSK
Upsteram and Downstream -Central system via intranet for acces to sales forecasts stock level at distribution centers,production & purchasing plans and deliveries in transit. Each supplier network member can access info about other members in the network. Performance monitoring system (VMI vs CMI)
OUTSOURCING
Glaxo has set up cross-functional teams in a sourcing group management. Seperate team for each commodity. Team Responsible for short term and long term procurement.
GSK outsourced to Enhance efficiency, Increase flexibility, and obtain expertise and skill not available to them
Ethics
Glaxo spends 8.4 billion pounds among 90,000 suppliers. New suppliers are audited against GSK standards Those not audited are trained to meet the standards.
CHALLENGES
Post merger Integration Issues Complex product portfolio Regulatory and operational challenges Outsourcing/supplier challenges Finding alternate/multiple suppliers Operational/production challenges Paperless labelling/electronic leaflets